Breakthrough Chemistry, Inc.
BKTH
$0.158
$0.04236.21%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.60K | 4.60K | 7.70K | 2.20K | 4.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.60K | 4.60K | 7.70K | 2.20K | 4.50K |
| Cost of Revenue | 3.30K | 3.30K | 10.00K | 1.20K | 3.30K |
| Gross Profit | 1.30K | 1.30K | -2.30K | 1.00K | 1.20K |
| SG&A Expenses | 14.50K | 14.50K | 92.30K | 32.00K | 10.20K |
| Depreciation & Amortization | 11.20K | 11.20K | 11.20K | 11.30K | 11.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.10K | 29.10K | 110.00K | 45.10K | 24.70K |
| Operating Income | -24.40K | -24.40K | -102.20K | -42.90K | -20.20K |
| Income Before Tax | -31.40K | -31.40K | -109.20K | -50.00K | -30.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.40K | -31.40K | -109.20K | -50.00K | -30.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.40K | -31.40K | -109.20K | -50.00K | -30.70K |
| EBIT | -24.40K | -24.40K | -102.20K | -42.90K | -20.20K |
| EBITDA | -13.20K | -13.20K | -91.10K | -31.70K | -8.90K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 9.73M | 9.73M | 9.73M | 9.73M | 9.10M |
| Average Diluted Shares Outstanding | 9.73M | 9.73M | 9.73M | 9.73M | 9.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |